Axogen, Inc. (AXGN)
Makes surgical implants that help repair damaged nerves.
$40.90-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+222.8%
The outlook
AXGN is trading near the upper end of its 52-week range, with analyst consensus strongly bullish and an average price target around 24% above the current level. The stock shows mixed momentum relative to its moving averages, suggesting some near-term choppiness despite the broad analyst support.
What’s behind the score
Analyst consensusStrong Buy — 1.2 avg of 9 analysts
Price trendMixed vs its moving averages
52-week range82% of the way from its 52-week low to high
Price targetAvg target +24% vs current price
Analyst price target
~12-month · 9 analysts$50.78average target+24.2% vs now
Now $40.90
Low $48.00High $55.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.17B
52-wk high
$46.95
52-wk low
$12.39
50-day avg
$42.01
200-day avg
$33.56
Trailing P/E
—